Need Physician Approval
Jakavi 20 Mg 56 Tablet
13,080.85
In stock
SKU :
104299
Oral therapy for myelofibrosis & polycythemia vera
Product Description
Jakavi (ruxolitinib) 20mg Tablets (56 pcs) are used to treat myelofibrosis and polycythemia vera. It works by inhibiting Janus kinase (JAK) pathways to reduce abnormal blood cell production.
Key Benefits
- Treats myelofibrosis & polycythemia vera
- Reduces abnormal blood cell counts
- Improves spleen size & symptoms
- Oral tablet for easy use
| Offer Label | Need Physician Approval |
|---|---|
| Shipping Type | Express |
Write Your Own Review